Evidence map›Paper›PMID 39209426›Full record

ArticleJournal of medical genetics2024

Loss-of-function variants in

Mridul Johari, Ana Topf, Chiara Folland, Jennifer Duff, Lein Dofash, Pilar Marti, Thomas Robertson, Juan Vilchez, Anita Cairns, Elizabeth Harris and 7 more

Abstract read
In one paragraph

Article in Journal of medical genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Effects ofAnimals : an open access journal from MDPI · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Mridul Johari *Harry Perkins Institute of Medical Research, Centre for Medical Research, University of Western Australia, Nedlands, Perth, Western Australia, Australia.ORCID 0000-0002-3549-558X
Ana Topf *The John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Chiara FollandHarry Perkins Institute of Medical Research, Centre for Medical Research, University of Western Australia, Nedlands, Perth, Western Australia, Australia.
Jennifer DuffThe John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Lein DofashHarry Perkins Institute of Medical Research, Centre for Medical Research, University of Western Australia, Nedlands, Perth, Western Australia, Australia.
Pilar MartiNeuromuscular Research Group, IIS La Fe and CIBERER U763, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
Thomas RobertsonAnatomical Pathology, Queensland Pathology, Brisbane, Queensland, Australia.
Juan VilchezNeuromuscular Research Group, IIS La Fe and CIBERER U763, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
Anita CairnsNeurosciences Department, Queensland Children's Hospital, Brisbane, Queensland, Australia.
Elizabeth HarrisThe John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Chiara Marini-BettoloThe John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Khalid HundallahDivision of Pediatric Neurology, Department of Pediatric, Prince Sultan Military Medical City, Riyadh, Riyadh, Saudi Arabia.
Amal M AlhashemDivision of clinical genetic and metabolic medicine, Department of Pediatric, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
Mohammed Al-OwainDepartment of Medical Genomics, Centre for Genomic Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Reza MaroofianDepartment of Neuromuscular Disorders, Queen Square Institute of Neurology, University College London, London, UK.
Gianina RavenscroftHarry Perkins Institute of Medical Research, Centre for Medical Research, University of Western Australia, Nedlands, Perth, Western Australia, Australia gina.ravenscroft@perkins.uwa.edu.au.ORCID 0000-0003-3634-211X
Volker StraubThe John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Funding

Joint Center for Mendelian GenomicsUM1HG008900 · NHGRI · BROAD INSTITUTE, INC. · PI O'DONNELL-LURIA, ANNE, REHM, HEIDI L · 2016 to 2020
$16.5M
A powerful web-based discovery platform for rare disease geneticsR01HG009141 · NHGRI · BROAD INSTITUTE, INC. · PI QUINLAN, AARON R, REHM, HEIDI L · 2017 to 2020
$2.9M
NHGRI NIH HHS R01 HG009141NHGRI NIH HHS UM1 HG008900
6 · The paper itself

Abstract

backgroundWeakness of facial, ocular and axial muscles is a common clinical presentation in congenital myopathies caused by pathogenic variants in genes encoding triad proteins. Abnormalities in triad structure and function resulting in disturbed excitation-contraction coupling and Ca

methodsWe analysed exome and genome sequencing data from four unrelated individuals with congenital myopathy characterised by facial, ocular and bulbar involvement. We collected deep phenotypic data from the affected individuals. We analysed the RNA-sequencing (RNA-seq) data of F3-II.1 and performed gene expression outlier analysis in 129 samples.

resultsThe four probands had a remarkably similar clinical presentation with prominent facial, ocular and bulbar features. Disease onset was in the neonatal period with hypotonia, poor feeding, cleft palate and talipes. Muscle weakness was generalised but prominent in the lower limbs with facial weakness also present. All patients had myopathic facies, bilateral ptosis, ophthalmoplegia and fatigability. Muscle biopsy on light microscopy showed type 1 myofiber predominance and ultrastructural analysis revealed slightly reduced triads, and structurally abnormal sarcoplasmic reticulum.DNA sequencing identified four unique homozygous loss-of-function variants in

conclusionsJunctophilin-1 is critical for the formation of skeletal muscle triad junctions by connecting the sarcoplasmic reticulum and T-tubules. Our findings suggest that loss of

Indexed as

PedigreeChildChild, PreschoolExome SequencingFemaleHumansInfantLoss of Function MutationMaleMyotonia CongenitaPhenotypecongenital, hereditary, and neonatal diseases and abnormalitiesexome sequencingneuromuscular diseasesRNA-seq

Identifiers

PMID39209426
PMCPMC11503096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.